Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes
Future research should prioritize well-designed epidemiological studies and randomized controlled trials in underrepresented income settings, as well as systematic reviews that formally assess risk of bias and regional underrepresentation in the literature
Weight loss reduces the production of these cytokines, lowering overall inflammation levels
A meta-analysis of randomized controlled trials found they can improve tendon structure, strength, and post-exercise recovery when combined with resistance training, though the quality of evidence remains moderate. Innovation is exciting, but recommending injectable, unregulated peptides to patients, without clinical validation should give us pause
Innovations such as nanoparticle carriers, liposomes, cyclodextrin complexes, and mucosal delivery methods show promise in preclinical studies